Your browser doesn't support javascript.
loading
Posaconazole-ibrutinib interaction cannot be avoided by staggered dosing: How to optimize ibrutinib dose during posaconazole treatment.
Olkkola, Aleksi M; Tapaninen, Tuija; Tornio, Aleksi; Hauta-Aho, Milka; Lapatto-Reiniluoto, Outi; Neuvonen, Mikko; Kiiski, Johanna I; Neuvonen, Pertti J; Niemi, Mikko; Backman, Janne T.
Afiliación
  • Olkkola AM; Department of Clinical Pharmacology, University of Helsinki, Helsinki, Finland.
  • Tapaninen T; Individualized Drug Therapy Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Tornio A; Department of Clinical Pharmacology, University of Helsinki, Helsinki, Finland.
  • Hauta-Aho M; Individualized Drug Therapy Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Lapatto-Reiniluoto O; Department of Clinical Pharmacology, HUS Diagnostic Center, Helsinki University Hospital, Helsinki, Finland.
  • Neuvonen M; Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.
  • Kiiski JI; Institute of Biomedicine, Faculty of Medicine, University of Turku, Turku, Finland.
  • Neuvonen PJ; Unit of Clinical Pharmacology, Turku University Hospital, Turku, Finland.
  • Niemi M; Department of Clinical Pharmacology, University of Helsinki, Helsinki, Finland.
  • Backman JT; Department of Clinical Pharmacology, HUS Diagnostic Center, Helsinki University Hospital, Helsinki, Finland.
Br J Clin Pharmacol ; 90(2): 557-567, 2024 02.
Article en En | MEDLINE | ID: mdl-37872104

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Piperidinas / Triazoles / Adenina / Citocromo P-450 CYP3A / Intervención Coronaria Percutánea Límite: Humans Idioma: En Revista: Br J Clin Pharmacol Año: 2024 Tipo del documento: Article País de afiliación: Finlandia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Piperidinas / Triazoles / Adenina / Citocromo P-450 CYP3A / Intervención Coronaria Percutánea Límite: Humans Idioma: En Revista: Br J Clin Pharmacol Año: 2024 Tipo del documento: Article País de afiliación: Finlandia